Brief: Irlab Board Resolves On SEK 136 Mln Rights Issue

IRLAB Therapeutics AB

24/06/2025 07:03

June 24 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:

BOARD RESOLVES ON SEK 136 MILLION RIGHTS ISSUE

SUBSCRIPTION PRICE SET AT SEK 3.50 PER SHARE

RIGHTS ISSUE 85% COVERED BY UNDERTAKINGS

Source text: ID:nMFN6nJKXB

Further company coverage: [IRLABa.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))